Onesource Specialty Pharma Share Price
1594.90+14.90 (+0.94%)
-13.36% past 1 Year
Corporate filings & documents
Announcements
Addendum to the notice of the 19th AGM scheduled to be held on September 23 2026
1 week agoAddendum to the notice of the 19th AGM scheduled to be held on September 23 2026
1 week agoIntimation of the investor presentation
2 weeks agoIntimation of the investor presentation
2 weeks agoNewspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting
2 weeks agoNewspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting
2 weeks agoIntimation of the Notice of the 19th AGM (2nd AGM after listing) to be held on September 23 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means
2 weeks agoIntimation of the Notice of the 19th AGM (2nd AGM after listing) to be held on September 23 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means
2 weeks agoBusiness Responsibility and Sustainability Report for the FY 2026
2 weeks agoBusiness Responsibility and Sustainability Report for the FY 2026
2 weeks agoAnnual Report for FY 2025-26
2 weeks agoAnnual Report for FY 2025-26
2 weeks agoAnnual Report for FY 2025-26
2 weeks agoAnnual Report for FY 2025-26
2 weeks agoIntimation of Investors called scheduled on September 03 2026 at 10:00 AM.
2 weeks agoIntimation of Investors called scheduled on September 03 2026 at 10:00 AM.
2 weeks agoNewspaper advertisement regarding the 19th Annual General Meeting of the Company
3 weeks agoNewspaper advertisement regarding the 19th Annual General Meeting of the Company
3 weeks agoIntimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17 2026
1 month agoIntimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17 2026
1 month agoIntimation of Transcript of Earnings call dated July 25 2026
1 month agoIntimation of Transcript of Earnings call dated July 25 2026
1 month agoChanges in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoChanges in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoIntimation about publication of newspaper advertisement- Extract of unaudited Standalone and Consolidated financial results for the quarter ended June 30 2026.
1 month agoIntimation about publication of newspaper advertisement- Extract of unaudited Standalone and Consolidated financial results for the quarter ended June 30 2026.
1 month agoIntimation of Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30 2026
1 month agoIntimation of Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30 2026
1 month agoIntimation of allotment of 2 900 ESOPs of Re.1 each under ONESOURCE ESOP 2021
1 month agoIntimation of allotment of 2 900 ESOPs of Re.1 each under ONESOURCE ESOP 2021
1 month agoOneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
1 month agoOneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
1 month agoChanges in the Senior Managament Personnel of the Company-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoChanges in the Senior Managament Personnel of the Company-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoOutcome of the Board meeting dated July 24 2026 for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.
1 month agoOutcome of the Board meeting dated July 24 2026 for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.
1 month agoIntimation of Earnings Call to be held on July 25 2026.
2 months agoIntimation of Earnings Call to be held on July 25 2026.
2 months agoOnesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.
2 months agoOnesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.
2 months agoOneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
2 months agoOneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
2 months agoWe refer to the intimation made earlier today by Dr. Reddys Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.
2 months agoWe refer to the intimation made earlier today by Dr. Reddys Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.
2 months agoAllotment of 24 190 equity shares of Re. 1/- under ONESOURCE ESOP 2021 on July 08 2026.
2 months agoAllotment of 24 190 equity shares of Re. 1/- under ONESOURCE ESOP 2021 on July 08 2026.
2 months agoWe wish to inform that a routine current Good Manufacturing (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility (SPD) of OneSource Specialty Pharma Limited from June 22 2026 to June 30 2026.The inspection has concluded with one observation. The Company will respond to the observation comprehensively to FDA within the stipulated time frame.
2 months agoWe wish to inform that a routine current Good Manufacturing (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility (SPD) of OneSource Specialty Pharma Limited from June 22 2026 to June 30 2026.The inspection has concluded with one observation. The Company will respond to the observation comprehensively to FDA within the stipulated time frame.
2 months agoIntimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30 2026.
2 months agoIntimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30 2026.
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
Jul 2026
ConcallPresentation
May 2026
Jan 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025